Kodiak Sciences Inc KOD EBITDA

EBITDA at other companies

Regeneron PharmaceuticalsREGN

$1.42B+16.7%

EyePoint, Inc.EYPT

-$96.69M-56.7%

KLR

Kalaris TherapeuticsKLRS

-$11.82M—

4D Molecular TherapeuticsFDMT

-$72.35M-37.6%

HRO

HarrowHROW

-$21.63M-101%

PVL

Palvella TherapeuticsPVLA

-$1.79M—

FAQ

What is Kodiak Sciences Inc's EBITDA?

Kodiak Sciences Inc (KOD) reported EBITDA of -$55.67M in Q1 2026.

How has Kodiak Sciences Inc's EBITDA changed year-over-year?

Kodiak Sciences Inc's EBITDA decreased by 2.2% year-over-year, from -$54.47M to -$55.67M.

What is the long-term trend for Kodiak Sciences Inc's EBITDA?

Over 4 years (2021 to 2025), Kodiak Sciences Inc's EBITDA has grown at a -5.1% compound annual growth rate (CAGR), from -$266.05M to -$216.06M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.